Top

CardioVascular and Interventional Radiology

Published in:

20-03-2024 | Retinoblastoma | Review

Advanced Interventional Treatments in Retinoblastoma Management: A Comprehensive Review

Authors: Peter Kolyvas, Aazrin Mir, Thomas Stirrat, Brittany Brookner, Nathanael Pilar, Eric Monroe, Rakesh Ahuja

Published in: CardioVascular and Interventional Radiology | Issue 4/2024

Abstract

Retinoblastoma is the most common eye malignancy in children that if left untreated can invade intraocular structures, metastasize, and rarely lead to death. Traditionally treated with systemic chemotherapy, Intra-arterial chemotherapy is gaining popularity as it allows for the direct administration of chemotherapy through the ophthalmic artery, thus reducing systemic side effects. Intra-arterial chemotherapy procedures have evolved, with refinements to reduce risks and radiation exposure. Intra-arterial chemotherapy boasts an impressive technical success rate and one year ocular survival even amongst advanced cases. This review offers a thorough examination of the technique, indications, contraindications, outcomes, and alternative options for Intra-arterial chemotherapy.

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.CrossRefPubMed

Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129–31. https://doi.org/10.1136/bjo.2008.150292.CrossRefPubMed

Fabian ID, Sagoo MS. Understanding retinoblastoma: epidemiology and genetics. Community Eye Health. 2018;31(101):7.PubMedPubMedCentral

Cruz-Gálvez CC, Ordaz-Favila JC, Villar-Calvo VM, Cancino-Marentes ME, Bosch-Canto V. Retinoblastoma: review and new insights. Front Oncol. 2022;12:963780. https://doi.org/10.3389/fonc.2022.963780.CrossRefPubMedPubMedCentral

Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021. https://doi.org/10.1038/nrdp.2015.21.CrossRefPubMedPubMedCentral

Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, Brisse H, Doz F, Desjardins L. Retinoblastoma. Orphanet J Rare Dis. 2006;1:31. https://doi.org/10.1186/1750-1172-1-31.CrossRefPubMedPubMedCentral

Monroe EJ, Otjen JP, Wright JN, et al. Prospective determination of orbital perfusion dominance before intra-arterial chemotherapy for retinoblastoma using time-of-flight magnetic resonance angiography. J Clinic Intervent Radiol isvir. 2022;07(01):064–8. https://doi.org/10.1055/s-0042-1743498.CrossRef

Chen Q, Zhang B, Dong Y, et al. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma. Cancer Chemother Pharmacol. 2020;85(4):723–30. https://doi.org/10.1007/s00280-020-04036-w.CrossRefPubMed

Runnels J, Acosta G, Rose A, et al. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clin Transl Oncol. 2021;23(10):2066–77. https://doi.org/10.1007/s12094-021-02610-z.CrossRefPubMed

10.

Rishi P, Agarwal A, Chatterjee P, Sharma T, Sharma M, Saravanan M, Ravikumar R. Intra-arterial chemotherapy for retinoblastoma: four-year results from tertiary center in India. Ocular Oncol Pathol. 2020;6(1):66–73. https://doi.org/10.1159/000500010.CrossRef

11.

Monroe EJ, Chick JFB, Stacey AW, et al. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols. Pediatr Radiol. 2021;51(4):649–57. https://doi.org/10.1007/s00247-020-04892-x.CrossRefPubMed

12.

Sweid A, Hammoud B, Weinberg JH, Texakalidis P, Xu V, Shivashankar K, Baldassari MP, Das S, Ramesh S, Tjoumakaris S, Shields CL, Ancona-Lezama D, Lim LS, Dalvin LA, Jabbour P. Intra-arterial chemotherapy for retinoblastoma in infants ≤10 kg: 74 treated eyes with 222 IAC sessions. AJNR Am J Neuroradiol. 2020;41(7):1286–92. https://doi.org/10.3174/ajnr.A6590.CrossRefPubMedPubMedCentral

13.

Liang T, Zhang X, Li J, Hua X, Zhao P, Ji X. Intra-arterial chemotherapy as primary treatment for advanced unilateral retinoblastoma in China. Front Med. 2022;9: 855661. https://doi.org/10.3389/fmed.2022.855661.CrossRef

14.

Saglam M, Sarici A, Anagnostakou V, et al. An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery. Neuroradiology. 2014;56(9):751–4. https://doi.org/10.1007/s00234-014-1388-1.CrossRefPubMed

15.

Abruzzo TA, Geller JI, Kimbrough DA, et al. Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy. J Neurointerv Surg. 2015;7(10):770–6. https://doi.org/10.1136/neurintsurg-2014-011295.CrossRefPubMed

16.

Chen Q, Zhang B, Dong Y, et al. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age. BMC Cancer. 2019;19(1):693. https://doi.org/10.1186/s12885-019-5844-5.CrossRefPubMedPubMedCentral

17.

Abramson DH, Daniels AB, Marr BP, et al. Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma. PLoS ONE. 2016;11(1):e0146582. https://doi.org/10.1371/journal.pone.0146582.CrossRefPubMedPubMedCentral

18.

Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118(10):2081–7. https://doi.org/10.1016/j.ophtha.2011.03.013.CrossRefPubMed

19.

Fabian ID, Reddy A, Sagoo MS. Classification and staging of retinoblastoma. Comm Eye Health. 2018;31(101):11–3.

20.

Shields CL, Dockery PW, Yaghy A, et al. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex. J Amer Assoc Pediatric Ophthalmol Strabismus. 2021;25(3):150.e1-150.e9. https://doi.org/10.1016/j.jaapos.2020.12.006.CrossRef

21.

Manjandavida FP, Stathopoulos C, Zhang J, Honavar SG, Shields CL. Intra-arterial chemotherapy in retinoblastoma—A paradigm change. Indian J Ophthalmol. 2019;67(6):740–54. https://doi.org/10.4103/ijo.IJO_866_19.CrossRefPubMedPubMedCentral

22.

Cao Y, Zhou M, Tian M, Lv HB. The safety and effectiveness of melphalan-based intra-arterial chemotherapy for retinoblastoma: an updated single-arm systematic review and meta-analysis. Evid Based Complement Alternat Med. 2022;2022:3156503. https://doi.org/10.1155/2022/3156503.CrossRefPubMedPubMedCentral

23.

Friedman EL, Froehler MT, Daniels AB. Orbital swelling in a child with retinoblastoma following intra-arterial chemotherapy. JAMA Ophthalmol. 2021;139(3):357. https://doi.org/10.1001/jamaophthalmol.2020.4675.CrossRefPubMed

24.

Stathopoulos C, Bartolini B, Marie G, Beck-Popovic M, Saliou G, Munier FL. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma. Ophthalmology. 2021;128(5):754–64. https://doi.org/10.1016/j.ophtha.2020.09.021.CrossRefPubMed

25.

Bogan CM, Kaczmarek JV, Pierce JM, et al. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. Br J Ophthalmol. 2021;106(2):288–96. https://doi.org/10.1136/bjophthalmol-2020-318529.CrossRefPubMed

26.

Zhou M, Wen X, Jia S, et al. Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy. Br J Ophthalmol. 2021;106(11):1581–6. https://doi.org/10.1136/bjophthalmol-2021-319118.CrossRefPubMed

27.

Daniels AB, Froehler MT, Kaczmarek JV, et al. Efficacy, toxicity, and pharmacokinetics of intra-arterial chemotherapy versus intravenous chemotherapy for retinoblastoma in animal models and patients. Transl Vision Sci Technol. 2021;10(11):10. https://doi.org/10.1167/tvst.10.11.10.CrossRef

28.

Francis JH, Levin AM, Zabor EC, Pierre GY, Abramson DH. Ten-year experience with ophthalmic artery chemosurgery: ocular and recurrence-free survival. PLoS ONE. 2018;13(5):e0197081. https://doi.org/10.1371/journal.pone.0197081.e0197081.CrossRefPubMedPubMedCentral

29.

Yousef YA, Soliman SE, Astudillo PPP, et al. Intra-arterial chemotherapy for retinoblastoma: a systematic review. JAMA Ophthalmol. 2016;134(5):584–91. https://doi.org/10.1001/jamaophthalmol.2016.0244.CrossRefPubMed

30.

Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276–80. https://doi.org/10.1016/j.ophtha.2006.06.018.CrossRefPubMed

31.

Wen X, Fan J, Jin M, et al. Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial. Lancet Child Adolesc Health. 2023;7(9):613–20. https://doi.org/10.1016/S2352-4642(23)00141-4.CrossRefPubMed

32.

Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: a 2020 review. Indian J Ophthalmol. 2020;68(11):2356–65. https://doi.org/10.4103/ijo.IJO_721_20.CrossRefPubMedPubMedCentral

33.

Shields CL, Lally SE, Leahey AM, et al. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Curr Opin Ophthalmol. 2014;25(5):374–85. https://doi.org/10.1097/ICU.0000000000000091.CrossRefPubMed

34.

Shields CL, Fulco EM, Arias JD, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond). 2013;27(2):253–64. https://doi.org/10.1038/eye.2012.175.CrossRefPubMed

35.

Chawla B, Jain A, Azad R. Conservative treatment modalities in retinoblastoma. Indian J Ophthalmol. 2013;61(9):479–85. https://doi.org/10.4103/0301-4738.119424.CrossRefPubMedPubMedCentral

36.

Shields CL, Shields JA, Kiratli H, De Potter PV. Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus. 1995;32(5):317–22. https://doi.org/10.3928/0191-3913-19950901-12.CrossRefPubMed

37.

Hasanreisoglu M, Saktanasate J, Schwendeman R, Shields JA, Shields CL. Indocyanine green-enhanced transpupillary thermotherapy for retinoblastoma: analysis of 42 tumors. J Pediatr Ophthalmol Strabismus. 2015;52(6):348–54. https://doi.org/10.3928/01913913-20150929-17.CrossRefPubMed

38.

Munier FL, Gaillard MC, Balmer A, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96(8):1078–83. https://doi.org/10.1136/bjophthalmol-2011-301450.CrossRefPubMed

39.

Yousef YA, Al Jboor M, Mohammad M, et al. Safety and efficacy of intravitreal chemotherapy (Melphalan) to treat vitreous seeds in retinoblastoma. Front Pharmacol. 2021;12:696787. https://doi.org/10.3389/fphar.2021.696787.CrossRefPubMedPubMedCentral

40.

Liang TY, Zhu XY, Hua XM, Ji XD, Zhao PQ. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma. Int J Ophthalmol. 2020;13(2):257–62. https://doi.org/10.18240/ijo.2020.02.09.CrossRefPubMedPubMedCentral

41.

Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108(3):260–4. https://doi.org/10.1016/0002-9394(89)90116-5.CrossRefPubMed

42.

Abramson DH, Ellsworth RM, Rozakis GW. Cryotherapy for retinoblastoma. Arch Ophthalmol. 1982;100(8):1253–6. https://doi.org/10.1001/archopht.1982.01030040231003.CrossRefPubMed

43.

Shields CL, Shields JA, De Potter P, et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology. 1993;100(2):216–24. https://doi.org/10.1016/s0161-6420(93)31667-2.CrossRefPubMed

44.

Kim JY, Park Y. Treatment of retinoblastoma: the role of external beam radiotherapy. Yonsei Med J. 2015;56(6):1478–91. https://doi.org/10.3349/ymj.2015.56.6.1478.CrossRefPubMedPubMedCentral

45.

Blach LE, McCormick B, Abramson DH. External beam radiation therapy and retinoblastoma: long-term results in the comparison of two techniques. Int J Radiat Oncol Biol Phys. 1996;35(1):45–51. https://doi.org/10.1016/s0360-3016(96)85010-3.CrossRefPubMed

46.

Shinohara ET, DeWees T, Perkins SM. Subsequent malignancies and their effect on survival in patients with retinoblastoma. Pediatr Blood Cancer. 2014;61(1):116–9. https://doi.org/10.1002/pbc.24714.CrossRefPubMed

47.

Aerts I, Sastre-Garau X, Savignoni A, et al. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation. J Clin Oncol. 2013;31(11):1458–63. https://doi.org/10.1200/JCO.2012.42.3962.CrossRefPubMed

Title: Advanced Interventional Treatments in Retinoblastoma Management: A Comprehensive Review
Authors: Peter Kolyvas
Aazrin Mir
Thomas Stirrat
Brittany Brookner
Nathanael Pilar
Eric Monroe
Rakesh Ahuja
Publication date: 20-03-2024
Publisher: Springer US
Keywords: Retinoblastoma
Retinoblastoma
Cytostatic Therapy
Cataract
Published in: CardioVascular and Interventional Radiology / Issue 4/2024
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-024-03692-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Advanced Interventional Treatments in Retinoblastoma Management: A Comprehensive Review

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2024

Evaluation of Local Vascular Perfusion in the Lower Extremities on Intravoxel Incoherent Motion Imaging before and after Endovascular Therapy

Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer

Feasibility of the FairEmbo Concept to Treat Women Postpartum Hemorrhage: Embolization with Suture Fragments

The IR Platypus

Procedural Blood Pressure and Intracranial Hemorrhage on Dual-Energy Computed Tomography After Endovascular Stroke Treatment

Immediate Angiography after Major Trauma: Establishing Feasibility Through Systems, Governance, and Infrastructure